Lineage Cell Therapeutics, Inc. Common Stock (LCTX)
0.6007
-0.0258 (-4.12%)
Lineage Cell Therapeutics Inc is a biotechnology company focused on developing innovative cell-based therapies for the treatment of a range of diseases, particularly those affecting the eye and nervous system
The company is dedicated to utilizing its proprietary technology and expertise in cell therapy to create regenerative medicine solutions that can improve patient outcomes. By leveraging advancements in stem cell research and regenerative medicine, Lineage aims to address unmet medical needs through its clinical programs and preclinical research initiatives, contributing to the evolution of therapeutic strategies in regenerative healthcare.
Frequently Asked Questions
Is Lineage Cell Therapeutics, Inc. Common Stock publicly traded?
Yes, Lineage Cell Therapeutics, Inc. Common Stock is publicly traded.
What exchange does Lineage Cell Therapeutics, Inc. Common Stock trade on?
Lineage Cell Therapeutics, Inc. Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Lineage Cell Therapeutics, Inc. Common Stock?
The ticker symbol for Lineage Cell Therapeutics, Inc. Common Stock is LCTX on the New York Stock Exchange
What is the current price of Lineage Cell Therapeutics, Inc. Common Stock?
The current price of Lineage Cell Therapeutics, Inc. Common Stock is 0.6007
When was Lineage Cell Therapeutics, Inc. Common Stock last traded?
The last trade of Lineage Cell Therapeutics, Inc. Common Stock was at 6:30 pm EST on January 31st, 2025
What is the market capitalization of Lineage Cell Therapeutics, Inc. Common Stock?
The market capitalization of Lineage Cell Therapeutics, Inc. Common Stock is 105.11M
How many shares of Lineage Cell Therapeutics, Inc. Common Stock are outstanding?
Lineage Cell Therapeutics, Inc. Common Stock has 174.99M shares outstanding.